ISRCTN97369178已完成未知
An exploratory study to test STASH (STis and Sexual Health), a peer-led intervention to prevent and reduce STI transmission and improve sexual health in secondary schools in UK
niversity of Glasgow (UK)0 个研究点目标入组 1,376 人开始时间: 2016年5月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,376
研究概览
简要总结
2018 Protocol article in https://pubmed.ncbi.nlm.nih.gov/30519482/ protocol (added 30/11/2020) 2020 Interim results article in https://doi.org/10.3310/phr08150 Feasibility results (added 15/01/2021) 2021 Interim results article in https://pubmed.ncbi.nlm.nih.gov/34127082/ Feasibility results (added 17/06/2021) 2023 Interim results article in https://pubmed.ncbi.nlm.nih.gov/37041542/ Intervention development and optimisation (added 12/04/2023) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33591287/ opportunities and challenges (added 10/07/2024)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •State-funded schools in the Lothian region of Scotland. All S4 students (aged 14-16; male and female) at eligible schools who have received, or are currently in receipt of teacher-led sex RSHP (Relationships, Sexual Health and Parenting), regardless of their sexual experience or individual level of risk.
排除标准
- •1. Faith schools in which STASH principles conflict with religious principles/teaching on sex education
- •2. Students in eligible schools who refuse their consent or whose parents/carers refuse consent
研究者
相似试验
已完成
不适用
Validation of a New TSH TestSub-clinical HypothyroidismEuthyroidismHypothyroidismNCT01997554Hospices Civils de Lyon1,654
已完成
不适用
WHITE 7 - WHISH – Wound Healing in Surgery for Hip fracturesISRCTN55305726niversity of Oxford464
已完成
不适用
Apixaban Validation Study - Additional Study on Fresh SamplesAnticoagulation With ApixabanNCT03073265Diagnostica Stago109
已完成
3 期
Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African ChildrenSchistosoma HaematobiumSchistosoma MansoniNCT03893097Institute of Tropical Medicine, Belgium726
招募中
3 期
A Study of SHR-A1811 in First-line Treatment of Patients With Advanced or Metastatic Non-small Cell Lung Cancer With HER2 MutationsNon-Small Cell Lung Cancer With HER2- MutationsNCT06430437Jiangsu HengRui Medicine Co., Ltd.300
